001     139838
005     20240321220708.0
024 7 _ |a 10.1093/brain/awx370
|2 doi
024 7 _ |a pmid:29342275
|2 pmid
024 7 _ |a pmc:PMC5837483
|2 pmc
024 7 _ |a 0006-8950
|2 ISSN
024 7 _ |a 1460-2156
|2 ISSN
024 7 _ |a altmetric:31582036
|2 altmetric
037 _ _ |a DZNE-2020-06160
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Brenner, David
|b 0
245 _ _ |a Hot-spot KIF5A mutations cause familial ALS.
260 _ _ |a Oxford
|c 2018
|b Oxford Univ. Press
264 _ 1 |3 online
|2 Crossref
|b Oxford University Press (OUP)
|c 2018-01-12
264 _ 1 |3 print
|2 Crossref
|b Oxford University Press (OUP)
|c 2018-03-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1631197322_23921
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift mutations in the C-terminal domain of KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome. These findings, together with the observation that many of the disease genes associated with amyotrophic lateral sclerosis disrupt cytoskeletal function and intracellular transport, led us to hypothesize that mutations in KIF5A are also a cause of amyotrophic lateral sclerosis. Using whole exome sequencing followed by rare variant analysis of 426 patients with familial amyotrophic lateral sclerosis and 6137 control subjects, we detected an enrichment of KIF5A splice-site mutations in amyotrophic lateral sclerosis (2/426 compared to 0/6137 in controls; P = 4.2 × 10-3), both located in a hot-spot in the C-terminus of the protein and predicted to affect splicing exon 27. We additionally show co-segregation with amyotrophic lateral sclerosis of two canonical splice-site mutations in two families. Investigation of lymphoblast cell lines from patients with KIF5A splice-site mutations revealed the loss of mutant RNA expression and suggested haploinsufficiency as the most probable underlying molecular mechanism. Furthermore, mRNA sequencing of a rare non-synonymous missense mutation (predicting p.Arg1007Gly) located in the C-terminus of the protein shortly upstream of the splice donor of exon 27 revealed defective KIF5A pre-mRNA splicing in respective patient-derived cell lines owing to abrogation of the donor site. Finally, the non-synonymous single nucleotide variant rs113247976 (minor allele frequency = 1.00% in controls, n = 6137), also located in the C-terminal region [p.(Pro986Leu) in exon 26], was significantly enriched in familial amyotrophic lateral sclerosis patients (minor allele frequency = 3.40%; P = 1.28 × 10-7). Our study demonstrates that mutations located specifically in a C-terminal hotspot of KIF5A can cause a classical amyotrophic lateral sclerosis phenotype, and underline the involvement of intracellular transport processes in amyotrophic lateral sclerosis pathogenesis.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2018-01-12
|2 Crossref
|u http://creativecommons.org/licenses/by-nc/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a KIF5A protein, human
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a Kinesin
|0 EC 3.6.4.4
|2 NLM Chemicals
650 _ 2 |a Kinesins: genetics
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: genetics
|2 MeSH
650 _ 2 |a DNA Mutational Analysis
|2 MeSH
650 _ 2 |a Family Health
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Genetic Association Studies
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Kinesin: genetics
|2 MeSH
650 _ 2 |a Lymphocytes: drug effects
|2 MeSH
650 _ 2 |a Lymphocytes: metabolism
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a RNA, Messenger: genetics
|2 MeSH
650 _ 2 |a RNA, Messenger: metabolism
|2 MeSH
700 1 _ |a Yilmaz, Rüstem
|b 1
700 1 _ |a Müller, Kathrin
|b 2
700 1 _ |a Grehl, Torsten
|b 3
700 1 _ |a Petri, Susanne
|b 4
700 1 _ |a Meyer, Thomas
|b 5
700 1 _ |a Grosskreutz, Julian
|b 6
700 1 _ |a Weydt, Patrick
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Ruf, Wolfgang
|0 P:(DE-2719)9001522
|b 8
|u dzne
700 1 _ |a Neuwirth, Christoph
|b 9
700 1 _ |a Weber, Markus
|b 10
700 1 _ |a Pinto, Susana
|b 11
700 1 _ |a Claeys, Kristl G
|b 12
700 1 _ |a Schrank, Berthold
|b 13
700 1 _ |a Jordan, Berit
|b 14
700 1 _ |a Knehr, Antje
|b 15
700 1 _ |a Günther, Kornelia
|b 16
700 1 _ |a Hübers, Annemarie
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Zeller, Daniel
|b 18
700 1 _ |a Kubisch, Christian
|b 19
700 1 _ |a Jablonka, Sibylle
|b 20
700 1 _ |a Sendtner, Michael
|b 21
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 22
700 1 _ |a de Carvalho, Mamede
|b 23
700 1 _ |a Sperfeld, Anne
|b 24
700 1 _ |a Borck, Guntram
|b 25
700 1 _ |a Volk, Alexander E
|b 26
700 1 _ |a Dorst, Johannes
|b 27
700 1 _ |a Weis, Joachim
|b 28
700 1 _ |a Otto, Markus
|b 29
700 1 _ |a Schuster, Joachim
|b 30
700 1 _ |a Del Tredici, Kelly
|b 31
700 1 _ |a Braak, Heiko
|b 32
700 1 _ |a Danzer, Karin M
|0 P:(DE-2719)9001513
|b 33
|u dzne
700 1 _ |a Freischmidt, Axel-Dieter
|0 P:(DE-2719)9001054
|b 34
|u dzne
700 1 _ |a Meitinger, Thomas
|0 P:(DE-2719)9000207
|b 35
|u dzne
700 1 _ |a Strom, Tim M
|b 36
700 1 _ |a Ludolph, Albert
|0 P:(DE-2719)2812633
|b 37
|u dzne
700 1 _ |a Andersen, Peter M
|b 38
700 1 _ |a Weishaupt, Jochen H
|0 P:(DE-2719)9000455
|b 39
|e Corresponding author
|u dzne
700 1 _ |a MND-NET, German ALS network
|b 40
700 1 _ |a Weyen, Ute
|b 41
700 1 _ |a Hermann, Andreas
|0 P:(DE-2719)2811732
|b 42
|u dzne
700 1 _ |a Hagenacker, Tim
|b 43
700 1 _ |a Koch, Jan Christoph
|b 44
700 1 _ |a Lingor, Paul
|0 P:(DE-2719)2812561
|b 45
|u dzne
700 1 _ |a Göricke, Bettina
|b 46
700 1 _ |a Zierz, Stephan
|b 47
700 1 _ |a Baum, Petra
|b 48
700 1 _ |a Wolf, Joachim
|b 49
700 1 _ |a Winkler, Andrea
|b 50
700 1 _ |a Young, Peter
|b 51
700 1 _ |a Bogdahn, Ulrich
|b 52
700 1 _ |a Prudlo, Johannes
|0 P:(DE-2719)2380559
|b 53
|u dzne
700 1 _ |a Kassubek, Jan
|b 54
773 1 8 |a 10.1093/brain/awx370
|b : Oxford University Press (OUP), 2018-01-12
|n 3
|p 688-697
|3 journal-article
|2 Crossref
|t Brain
|v 141
|y 2018
|x 0006-8950
773 _ _ |a 10.1093/brain/awx370
|g Vol. 141, no. 3, p. 688 - 697
|0 PERI:(DE-600)1474117-9
|n 3
|q 141:3<688 - 697
|p 688-697
|t Brain
|v 141
|y 2018
|x 0006-8950
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837483
909 C O |p VDB
|o oai:pub.dzne.de:139838
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 8
|6 P:(DE-2719)9001522
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2810704
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 33
|6 P:(DE-2719)9001513
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 34
|6 P:(DE-2719)9001054
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 35
|6 P:(DE-2719)9000207
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 37
|6 P:(DE-2719)2812633
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 39
|6 P:(DE-2719)9000455
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 42
|6 P:(DE-2719)2811732
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 45
|6 P:(DE-2719)2812561
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 53
|6 P:(DE-2719)2380559
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-09
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-09
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
920 1 _ |0 I:(DE-2719)1111016
|k Clinical Dementia Research München
|l Clinical Dementia Research München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a UNRESTRICTED
999 C 5 |y 2005
|2 Crossref
|o Andersen 2005
999 C 5 |y 2012
|2 Crossref
|o Andersen 2012
999 C 5 |y 2013
|2 Crossref
|o Braak 2013
999 C 5 |y 2017
|2 Crossref
|o Braak 2017
999 C 5 |y 2016
|2 Crossref
|o Brenner 2016
999 C 5 |y 2014
|2 Crossref
|o Brettschneider 2014
999 C 5 |y 2002
|2 Crossref
|o Celniker 2002
999 C 5 |y 2009
|2 Crossref
|o Chiò 2009
999 C 5 |y 2011
|2 Crossref
|o Deng 2011
999 C 5 |y 2016
|2 Crossref
|o Duis 2016
999 C 5 |y 2014
|2 Crossref
|o Fagerberg 2014
999 C 5 |y 1994
|2 Crossref
|o Figlewicz 1994
999 C 5 |y 2015
|2 Crossref
|o Freischmidt 2015
999 C 5 |y 2008
|2 Crossref
|o Gitcho 2008
999 C 5 |y 2009
|2 Crossref
|o Goizet 2009
999 C 5 |y 2004
|2 Crossref
|o Gros-Louis 2004
999 C 5 |y 2017
|2 Crossref
|o Guinto 2017
999 C 5 |y 2013
|2 Crossref
|o Herder 2013
999 C 5 |y 2009
|2 Crossref
|o Hirokawa 2009
999 C 5 |y 2016
|2 Crossref
|o Kaji 2016
999 C 5 |y 2016
|2 Crossref
|o Kenna 2016
999 C 5 |y 2008
|2 Crossref
|o Kimonis 2008
999 C 5 |y 2008
|2 Crossref
|o Kühnlein 2008
999 C 5 |y 2016
|2 Crossref
|o Lek 2016
999 C 5 |y 2001
|2 Crossref
|o Livak 2001
999 C 5 |y 2014
|2 Crossref
|o Liu 2014
999 C 5 |y 2017
|2 Crossref
|o McLaughlin 2017
999 C 5 |y 2017
|2 Crossref
|o Morais 2017
999 C 5 |y 2012
|2 Crossref
|o Nakajima 2012
999 C 5 |y 2018
|2 Crossref
|o Nguyen 2018
999 C 5 |y 1994
|2 Crossref
|o Niclas 1994
999 C 5 |y 2009
|2 Crossref
|o Örlén 2009
999 C 5 |y 2003
|2 Crossref
|o Puls 2003
999 C 5 |y 2013
|2 Crossref
|o Randall 2013
999 C 5 |y 2002
|2 Crossref
|o Reid 2002
999 C 5 |y 2017
|2 Crossref
|o Rydzanicz 2017
999 C 5 |y 2014
|2 Crossref
|o Smith 2014
999 C 5 |y 2013
|2 Crossref
|o Tan 2013
999 C 5 |y 2012
|2 Crossref
|o Van Blitterswijk 2012
999 C 5 |y 2010
|2 Crossref
|o Wang 2010
999 C 5 |y 2012
|2 Crossref
|o Wu 2012
999 C 5 |y 2001
|2 Crossref
|o Yang 2001


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21